Khadka B(1), Lee JY(2), Park EK(3), Kim KT(1)(4), Bae JS(5). Author information:
(1)Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four,
Mokpo National University, Muan-gun, Jeonnam 58554, Korea.
(2)College of Pharmacy, Chungnam National University, Daejeon 34134, Korea.
(3)Department of Pathology and Regenerative Medicine, School of Dentistry,
Kyungpook National University, Daegu 41940, Korea.
(4)College of Pharmacy and Natural Medicine Research Institute, Mokpo National
University, Muan-gun, Jeonnam 58554, Korea.
(5)College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook
National University, Daegu 41566, Korea.
Natural compounds such as herbal medicines and/or phyto-compounds from foods, have frequently been used to exert synergistic therapeutic effects with anti-brain disorder drugs, supplement the effects of nutrients, and boost the immune system. However, co-administration of natural compounds with the drugs can cause synergistic toxicity or impeditive drug interactions due to changes in pharmacokinetic properties (e.g., absorption, metabolism, and excretion) and various drug transporters, particularly brain transporters. In this review, natural compound-drug interactions (NDIs), which can occur during the treatment of brain disorders, are emphasized from the perspective of pharmacokinetics and cellular transport. In addition, the challenges emanating from NDIs and recent approaches are discussed.
Having over 250 Research scholars worldwide and more than 400 articles online with open access.